Data

New technologies in the neurological field: What can I use today? And what is coming?

Today, evoked potentials and OCT are routinely used to detect subclinical involvement of eloquent pathways, to confirm relapses or to monitor demyelination, remyelination and axonal loss in trials targeting remyelination and neuroprotection. On the other hand, extensive research, also on a large scale, is being conducted to validate and promote the use of digital technologies for remote monitoring, with the final aim to ease disease management and to allow to empower self-monitoring by people with MS. All these measures, to be integrated in the large portfolio already available including biomarkers and neuroimaging, will require computing power and novel processing techniques, from statistical approaches to artificial intelligence.

BIOGRAPHY

LETIZIA LEOCANI

Letizia Leocani is Associate professor of Neurology at Vita-Salute San Raffaele University, Neurologist in the Neurorehabilitation Unit of the Neurological Dep.t and supervisor of the Experimental neurophysiology Unit and of Magnetic IntraCerebral Stimulation (MagICSI) center – Institute of Experimental Neurology, IRCCS Ospedale San Raffaele (COI).

After her medical degree, she obtained a PhD in Human Physiology and Neurology specialty and she has been Research Fellow at the Human Motor Control Section of the National Institutes of Health in Bethesda-USA. She is Co-Chair of the Clinical Neurophysiology scientific panel of the European Academy of Neurology.

Her fields of interest involve translational validation of electrophysiological (advanced EEG analysis, evoked and cognitive potentials) and structural (optical coherence tomography – OCT) markers of diseases of the central nervous system and of treatment strategies using non invasive brain stimulation to potentiate the effects of drugs and neurorehabilitation.rofessor